Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has received an average rating of “Moderate Buy” from the twenty research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and fourteen have given a buy recommendation to the […]
Veeva Systems (NYSE:VEEV – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Raymond James in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $260.00 target price on the technology company’s stock. Raymond James’ price objective points to a potential upside of 11.53% from the […]
Veeva Systems (NYSE:VEEV – Get Free Report)‘s stock had its “outperform” rating reissued by stock analysts at Raymond James in a research report issued on Tuesday, Benzinga reports. They presently have a $260.00 price objective on the technology company’s stock. Raymond James’ target price suggests a potential upside of 11.53% from the company’s current price. […]
StockNews.com cut shares of American Homes 4 Rent (NYSE:AMH – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Several other equities analysts have also commented on the stock. BNP Paribas started coverage on shares of American Homes 4 Rent in a research note on Monday, January 22nd. […]
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target raised by Jonestrading from $52.00 to $56.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on CRNX. Citigroup started coverage on Crinetics Pharmaceuticals in a research […]